Chronotype and cellular circadian rhythms predict the clinical response to lithium maintenance treatment in patients with bipolar disorder

Neuropsychopharmacology

Volumn 44, Issue 3, 2019, Pages 620-628

  McCarthy, Michael J ^a,b   Wei, Heather ^b   Nievergelt, Caroline M ^a   Stautland, Andrea ^c   Maihofer, Adam X ^a   Welsh, David K ^a,b   Shilling, Paul ^a   Alda, Martin ^d   Alliey Rodriguez, Ney ^e   Anand, Amit ^f   Andreasson, Ole A ^g   Balaraman, Yokesh ^f   Berrettini, Wade H ^h   Bertram, Holli ⁱ   Brennand, Kristen J ^j   Calabrese, Joseph R ^k   Calkin, Cynthia V ^d   Claasen, Ana ^l   Conroy, Clara ^k   Coryell, William H ^m   Craig, David W ^l   D’Arcangelo, Nicole ^k   Demodena, Anna ^b   Djurovic, Srdjan ^g   Feeder, Scott ⁿ   Fisher, Carrie ^f   Frazier, Nicole ⁱ   Frye, Mark A ⁿ   Gage, Fred H ^o   Gao, Keming ^k   Garnham, Julie ^d   Gershon, Elliot S ^e   Glazer, Kara ^p   Goes, Fernando ^p   Goto, Toyomi ^k   Harrington, Gloria ⁱ   Jakobsen, Petter ^q   Kamali, Masoud ⁱ   Karberg, Elizabeth ^k   Kelly, Marisa ⁱ   Leckband, Susan G ^b   Lohoff, Falk ^h   McInnis, Melvin G ⁱ   Mondimore, Francis ^p   Morken, Gunnar ^r   Nurnberger, John I ^f   Obral, Sarah ^k   Oedegaard, Ketil J ^c,q   Ortiz, Abigail ^s   Ritchey, Megan ^p   Ryan, Kelly ⁱ   Schinagle, Martha ^k   Schoeyen, Helle ^c   Schwebel, Candice ^h   Shaw, Martha ^e   Shekhtman, Tatyana ^a,b   Slaney, Claire ^d   Stapp, Emma ^p   Szelinger, Szabolcs ^l   Tarwater, Bruce ^l   Zandi, Peter P ^p   Kelsoe, John R ^a,b   more..

^a San Diego   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF BERGEN   (Norway)

^d DALHOUSIE UNIVERSITY   (Canada)

^e UNIVERSITY OF CHICAGO   (United States)

^f INDIANA UNIVERSITY   (United States)

^g UNIVERSITY OF OSLO   (Norway)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

^j MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^k CASE WESTERN RESERVE UNIVERSITY   (United States)

^l TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^m UNIVERSITY OF IOWA   (United States)

ⁿ MAYO CLINIC   (United States)

^o SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^p JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^r TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^s UNIVERSITY OF OTTAWA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL TRISPHOSPHATE; LITHIUM; CIRCADIAN RHYTHM SIGNALING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; ITPR3 PROTEIN, MOUSE; LITHIUM DERIVATIVE; PER2 PROTEIN, MOUSE; TRANQUILIZER;

ANIMAL CELL; ARTICLE; BIOLUMINESCENCE; BIPOLAR I DISORDER; CHRONOTROPISM; CIRCADIAN RHYTHM; CLINICAL OUTCOME; DEPRESSION; DOSAGE SCHEDULE COMPARISON; EVENING DOSAGE; GENETIC VARIATION; HUMAN; HUMAN CELL; INSOMNIA; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MANIA; MONOTHERAPY; MOOD DISORDER; MORNING DOSAGE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; SYMPTOMATOLOGY; TREATMENT RESPONSE; ADULT; ANIMAL; BIPOLAR DISORDER; CELL CULTURE; DRUG EFFECT; FIBROBLAST; GENETICS; GENOTYPING TECHNIQUE; LUMINESCENCE; MOUSE; NIH 3T3 CELL LINE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANIMALS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CELLS, CULTURED; CIRCADIAN RHYTHM; FIBROBLASTS; GENOTYPING TECHNIQUES; HUMANS; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; LITHIUM COMPOUNDS; LUMINESCENT MEASUREMENTS; MICE; NIH 3T3 CELLS; PERIOD CIRCADIAN PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES;

EID: 85057453787     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/s41386-018-0273-8     Document Type: Article

References (55)

1. Baldessarini RJ, Tondo L, Hennen J. Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry. 2003;64:44–52
2. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011;68:241–51. 10.1001/archgenpsychiatry.2011.12
3. McKenna BS, Drummond SP, Eyler LT. Associations between circadian activity rhythms and functional brain abnormalities among euthymic bipolar patients: a preliminary study. J Affect Disord. 2014;164:101–6. 10.1016/j.jad.2014.04.034
4. Jones SH, Hare DJ, Evershed K. Actigraphic assessment of circadian activity and sleep patterns in bipolar disorder. Bipolar Disord. 2005;7:176–86. 10.1111/j.1399-5618.2005.00187.x
5. Pagani L, St Clair PA, Teshiba TM, Service SK, Fears SC, Araya C, et al. Genetic contributions to circadian activity rhythm and sleep pattern phenotypes in pedigrees segregating for severe bipolar disorder. Proc Natl Acad Sci USA. 2016;113:E754–61. 10.1073/pnas.1513525113
6. Gonzalez R, Tamminga CA, Tohen M, Suppes T. The relationship between affective state and the rhythmicity of activity in bipolar disorder. J Clin Psychiatry. 2014;75:e317–22. 10.4088/JCP.13m08506
7. Harvey AG. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry. 2008;165:820–9. 10.1176/appi.ajp.2008.08010098
8. Souetre E, Salvati E, Wehr TA, Sack DA, Krebs B, Darcourt G. Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects. Am J Psychiatry. 1988;145:1133–7. 10.1176/ajp.145.9.1133
9. Moon JH, Cho CH, Son GH, Geum D, Chung S, Kim H, et al. Advanced Circadian Phase in Mania and Delayed Circadian Phase in Mixed Mania and Depression Returned to Normal after Treatment of Bipolar Disorder. EBioMedicine. 2016;11:285–95. 10.1016/j.ebiom.2016.08.019
10. Robillard R, Naismith SL, Rogers NL, Scott EM, Ip TK, Hermens DF, et al. Sleep-wake cycle and melatonin rhythms in adolescents and young adults with mood disorders: comparison of unipolar and bipolar phenotypes. Eur Psychiatry. 2013;28:412–6. 10.1016/j.eurpsy.2013.04.001
11. Partch CL, Green CB, Takahashi JS. Molecular architecture of the mammalian circadian clock. Trends Cell Biol. 2014;24:90–9. 10.1016/j.tcb.2013.07.002
12. Roybal K, Theobold D, Graham A, DiNieri JA, Russo SJ, Krishnan V, et al. Mania-like behavior induced by disruption of CLOCK. Proc Natl Acad Sci USA. 2007;104:6406–11. 10.1073/pnas.0609625104
13. Landgraf D, Long JE, Proulx CD, Barandas R, Malinow R, Welsh DK. Genetic disruption of circadian rhythms in the suprachiasmatic nucleus causes helplessness, behavioral despair, and anxiety-like behavior in mice. Biol Psychiatry. 2016;80:827–35. 10.1016/j.biopsych.2016.03.1050
14. Schnell A, Sandrelli F, Ranc V, Ripperger JA, Brai E, Alberi L, et al. Mice lacking circadian clock components display different mood-related behaviors and do not respond uniformly to chronic lithium treatment. Chronobiol Int. 2015;32:1075–89. 10.3109/07420528.2015.1062024
15. Li JZ, Bunney BG, Meng F, Hagenauer MH, Walsh DM, Vawter MP, et al. Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci USA. 2013;110:9950–5. 10.1073/pnas.1305814110
16. Lane JM, Vlasac I, Anderson SG, Kyle SD, Dixon WG, Bechtold DA, et al. Genome-wide association analysis identifies novel loci for chronotype in 100,420 individuals from the UK Biobank. Nat Commun. 2016;7:10889. 10.1038/ncomms10889
17. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM, et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science. 2001;291:1040–3
18. Patke A, Murphy PJ, Onat OE, Krieger AC, Ozcelik T, Campbell SS, et al. Mutation of the human circadian clock gene CRY1 in familial delayed sleep phase disorder. Cell. 2017;169:203–15 e13. 10.1016/j.cell.2017.03.027
19. McCarthy MJ, Wei H, Marnoy Z, Darvish RM, McPhie DL, Cohen BM, et al. Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients. Transl Psychiatry. 2013;3:e318. 10.1038/tp.2013.90
20. Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2006;163:217–24. 10.1176/appi.ajp.163.2.217
21. Licht RW, Vestergaard P, Rasmussen NA, Jepsen K, Brodersen A, Hansen PE. A lithium clinic for bipolar patients: 2-year outcome of the first 148 patients. Acta Psychiatr Scand. 2001;104:387–90
22. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry. 2003;60:497–502. 10.1001/archpsyc.60.5.497
23. Grof P, Duffy A, Cavazzoni P, Grof E, Garnham J, MacDougall M, et al. Is response to prophylactic lithium a familial trait? J Clin Psychiatry. 2002;63:942–7
24. Song J, Bergen SE, Di Florio A, Karlsson R, Charney A, Ruderfer DM, et al. Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder. Mol Psychiatry. 2015. 10.1038/mp.2015.165
25. Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N, et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet. 2016. 10.1016/S0140-6736(16)00143-4
26. Berridge MJ, Downes CP, Hanley MR. Neural and developmental actions of lithium: a unifying hypothesis. Cell. 1989;59:411–9
27. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA. 1996;93:8455–9
28. Wei H, Landgraf D, Wang G, McCarthy MJ. Inositol polyphosphates contribute to cellular circadian rhythms: Implications for understanding lithium's molecular mechanism. Cell Signal. 2018;44:82–91. 10.1016/j.cellsig.2018.01.001
29. Harada Y, Sakai M, Kurabayashi N, Hirota T, Fukada Y. Ser-557-phosphorylated mCRY2 is degraded upon synergistic phosphorylation by glycogen synthase kinase-3 beta. J Biol Chem. 2005;280:31714–21. 10.1074/jbc.M506225200
30. Iitaka C, Miyazaki K, Akaike T, Ishida N. A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J Biol Chem. 2005;280:29397–402. 10.1074/jbc.M503526200
31. Yin L, Wang J, Klein PS, Lazar MA. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science. 2006;311:1002–5. 10.1126/science.1121613
32. Hirota T, Lewis WG, Liu AC, Lee JW, Schultz PG, Kay SA. A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta. Proc Natl Acad Sci USA. 2008;105:20746–51. 10.1073/pnas.0811410106
33. Landgraf D, Joiner WJ, McCarthy MJ, Kiessling S, Barandas R, Young JW, et al. The mood stabilizer valproic acid opposes the effects of dopamine on circadian rhythms. Neuropharmacology. 2016;107:262–70. 10.1016/j.neuropharm.2016.03.047
34. Wu JC, Kelsoe JR, Schachat C, Bunney BG, DeModena A, Golshan S, et al. Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry. 2009;66:298–301. 10.1016/j.biopsych.2009.02.018
35. Oedegaard KJ, Alda M, Anand A, Andreassen OA, Balaraman Y, Berrettini WH, et al. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample. BMC Psychiatry. 2016;16:129. 10.1186/s12888-016-0732-x
36. Brown FM. Psychometric equivalence of an improved Basic Language Morningness (BALM) scale using industrial population within comparisons. Ergonomics. 1993;36:191–7. 10.1080/00140139308967872
37. Rhee MK, Lee HJ, Rex KM, Kripke DF. Evaluation of two circadian rhythm questionnaires for screening for the delayed sleep phase disorder. Psychiatry Investig. 2012;9:236–44. 10.4306/pi.2012.9.3.236
38. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54:573–83
39. Altman EG, Hedeker DR, Janicak PG, Peterson JL, Davis JM. The Clinician-Administered Rating Scale for Mania (CARS-M): development, reliability, and validity. Biol Psychiatry. 1994;36:124–34
40. McCarthy MJ, LeRoux M, Wei H, Beesley S, Kelsoe JR, Welsh DK. Calcium channel genes associated with bipolar disorder modulate lithium's amplification of circadian rhythms. Neuropharmacology.2015. 10.1016/j.neuropharm.2015.10.017
41. McCarthy MJ, Wei H, Landgraf D, Le Roux MJ, Welsh DK. Disinhibition of the extracellular-signal-regulated kinase restores the amplification of circadian rhythms by lithium in cells from bipolar disorder patients. Eur Neuropsychopharmacol. 2016;26:1310–9. 10.1016/j.euroneuro.2016.05.003
42. Nievergelt CM, Maihofer AX, Shekhtman T, Libiger O, Wang X, Kidd KK, et al. Inference of human continental origin and admixture proportions using a highly discriminative ancestry informative 41-SNP panel. Investig Genet. 2013;4:13. 10.1186/2041-2223-4-13
43. Chan JW, Lam SP, Li SX, Yu MW, Chan NY, Zhang J, et al. Eveningness and insomnia: independent risk factors of nonremission in major depressive disorder. Sleep. 2014;37:911–7. 10.5665/sleep.3658
44. PGC-BD. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. 2011;43:977–83. 10.1038/ng.943
45. Czeisler CA, Duffy JF, Shanahan TL, Brown EN, Mitchell JF, Rimmer DW, et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science. 1999;284:2177–81
46. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA. 2009;106:4453–8. 10.1073/pnas.0808180106
47. Santhi N, Lazar AS, McCabe PJ, Lo JC, Groeger JA, Dijk DJ. Sex differences in the circadian regulation of sleep and waking cognition in humans. Proc Natl Acad Sci USA. 2016;113:E2730–9. 10.1073/pnas.1521637113
48. Jansen PR, Watanabe K, Stringer S, Skene N, Bryois J, Hammerschlag AR, et al. Genome-wide analysis of insomnia (N=1,331,010) identifies novel loci and functional pathways. bioRxiv. 2018. 10.1101/214973
49. Stahl E, Breen G, Forstner A, McQuillin A, Ripke S, Cichon S, et al. Genomewide association study identifies 30 loci associated with bipolar disorder. bioRxiv. 2018. 10.1101/173062
50. Bouchard-Cannon P, Mendoza-Viveros L, Yuen A, Kaern M, Cheng HY. The circadian molecular clock regulates adult hippocampal neurogenesis by controlling the timing of cell-cycle entry and exit. Cell Rep. 2013;5:961–73. 10.1016/j.celrep.2013.10.037
51. Schnell A, Chappuis S, Schmutz I, Brai E, Ripperger JA, Schaad O, et al. The nuclear receptor REV-ERBalpha regulates Fabp7 and modulates adult hippocampal neurogenesis. PLoS ONE. 2014;9:e99883. 10.1371/journal.pone.0099883
52. Angelucci F, Aloe L, Jimenez-Vasquez P, Mathe AA. Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. Int J Neuropsychopharmacol. 2003;6:225–31. 10.1017/S1461145703003468
53. Begliuomini S, Lenzi E, Ninni F, Casarosa E, Merlini S, Pluchino N, et al. Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol. 2008;197:429–35. 10.1677/JOE-07-0376
54. Berchtold NC, Oliff HS, Isackson P, Cotman CW. Hippocampal BDNF mRNA shows a diurnal regulation, primarily in the exon III transcript. Brain Res Mol Brain Res. 1999;71:11–22
55. Liang FQ, Walline R, Earnest DJ. Circadian rhythm of brain-derived neurotrophic factor in the rat suprachiasmatic nucleus. Neurosci Lett. 1998;242:89–92